ClinVar Miner

Submissions for variant NM_000218.3(KCNQ1):c.1892C>G (p.Pro631Arg)

gnomAD frequency: 0.00002  dbSNP: rs1432436411
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color Diagnostics, LLC DBA Color Health RCV001843080 SCV001345964 uncertain significance Cardiac arrhythmia 2021-07-07 criteria provided, single submitter clinical testing This missense variant replaces proline with arginine at codon 631 of the KCNQ1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 3/188540 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
GeneDx RCV001751321 SCV001996495 uncertain significance not provided 2019-09-30 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function
Ambry Genetics RCV002411684 SCV002719175 uncertain significance Cardiovascular phenotype 2020-07-06 criteria provided, single submitter clinical testing The p.P631R variant (also known as c.1892C>G), located in coding exon 16 of the KCNQ1 gene, results from a C to G substitution at nucleotide position 1892. The proline at codon 631 is replaced by arginine, an amino acid with dissimilar properties. This variant was identified in an individual with long QT syndrome (Krahn AD et al. Circ Arrhythm Electrophysiol, 2012 Oct;5:933-40). It was also identified in a child with congenital erythropoietic porphyria with no information provided regarding cardiac status or evaluations provided (Wang J et al. Genome Med, 2015 Jul;7:77). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Labcorp Genetics (formerly Invitae), Labcorp RCV002560809 SCV003033266 uncertain significance Long QT syndrome 2025-01-08 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 631 of the KCNQ1 protein (p.Pro631Arg). This variant is present in population databases (no rsID available, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with KCNQ1-related conditions. ClinVar contains an entry for this variant (Variation ID: 921471). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt KCNQ1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
All of Us Research Program, National Institutes of Health RCV002560809 SCV004836501 uncertain significance Long QT syndrome 2024-03-24 criteria provided, single submitter clinical testing This missense variant replaces proline with arginine at codon 631 of the KCNQ1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 3/188540 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.